A citation-based method for searching scientific literature

Anirudh Manoj, Subham Das, Anu Kunnath Ramachandran, Angel T Alex, Alex Joseph. Future Med Chem 2020
Times Cited: 12







List of co-cited articles
43 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review.
Kashif Haider, Ankita Pathak, Ankit Rohilla, Md Rafi Haider, Kamal Ahmad, M Shahar Yar. Eur J Med Chem 2019
10
30

Biology of human sodium glucose transporters.
Ernest M Wright, Donald D F Loo, Bruce A Hirayama. Physiol Rev 2011
824
25

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.
Elisabetta Traggiai, Stephan Becker, Kanta Subbarao, Larissa Kolesnikova, Yasushi Uematsu, Maria Rita Gismondo, Brian R Murphy, Rino Rappuoli, Antonio Lanzavecchia. Nat Med 2004
525
16

Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review.
Subham Das, Anu K R, Sumit Raosaheb Birangal, Ajinkya Nitin Nikam, Abhijeet Pandey, Srinivas Mutalik, Alex Joseph. Life Sci 2020
21
16

[Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures].
R A Khamitov, S Ia Loginova, V N Shchukina, S V Borisevich, V A Maksimov, A M Shuster. Vopr Virusol 2008
115
16

The management of coronavirus infections with particular reference to SARS.
Samson S Y Wong, Kwok-Yung Yuen. J Antimicrob Chemother 2008
66
16

Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements.
Abhjieet Pandey, Ajinkya Nitin Nikam, Ajjappla Basavaraj Shreya, Sadhana P Mutalik, Divya Gopalan, Sanjay Kulkarni, Bharath Singh Padya, Gasper Fernandes, Srinivas Mutalik, Ruth Prassl. Life Sci 2020
61
16

Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells.
Mohsin Khan, S R Santhosh, Mugdha Tiwari, P V Lakshmana Rao, Manmohan Parida. J Med Virol 2010
126
16


Coronavirus biology and replication: implications for SARS-CoV-2.
Philip V'kovski, Annika Kratzel, Silvio Steiner, Hanspeter Stalder, Volker Thiel. Nat Rev Microbiol 2021
16

Mesenchymal stem cells for acute lung injury: preclinical evidence.
Michael A Matthay, Arnaud Goolaerts, James P Howard, Jae Woo Lee. Crit Care Med 2010
120
16

Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids.
B M Jones, E S K Ma, J S M Peiris, P C Wong, J C M Ho, B Lam, K N Lai, K W T Tsang. Clin Exp Immunol 2004
49
16

Neurodegenerative Pathways in Alzheimer's Disease: A Review.
Anu Kunnath Ramachandran, Subham Das, Alex Joseph, Gurupur Gautham Shenoy, Angel Treasa Alex, Jayesh Mudgal. Curr Neuropharmacol 2021
7
28

Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha.
Ute Ströher, Antonino DiCaro, Yan Li, James E Strong, Fred Aoki, Frank Plummer, Steven M Jones, Heinz Feldmann. J Infect Dis 2004
149
16

An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent.
Sushanta Bhattacharya, Akash Rathore, Deepa Parwani, Chaitali Mallick, Vivek Asati, Shivangi Agarwal, Vaibhav Rajoriya, Ratnesh Das, Sushil Kumar Kashaw. Eur J Med Chem 2020
13
16

Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.
Carmen Hierro-Bujalance, Carmen Infante-Garcia, Angel Del Marco, Marta Herrera, Maria Jose Carranza-Naval, Javier Suarez, Pilar Alves-Martinez, Simon Lubian-Lopez, Monica Garcia-Alloza. Alzheimers Res Ther 2020
39
16

Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice.
Paul Millar, Nupur Pathak, Vadivel Parthsarathy, Anthony J Bjourson, Maurice O'Kane, Varun Pathak, R Charlotte Moffett, Peter R Flatt, Victor A Gault. J Endocrinol 2017
46
16

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.
Brendon L Neuen, Tamara Young, Hiddo J L Heerspink, Bruce Neal, Vlado Perkovic, Laurent Billot, Kenneth W Mahaffey, David M Charytan, David C Wheeler, Clare Arnott,[...]. Lancet Diabetes Endocrinol 2019
382
16

Regional distribution of SGLT activity in rat brain in vivo.
Amy S Yu, Bruce A Hirayama, Gerald Timbol, Jie Liu, Ana Diez-Sampedro, Vladimir Kepe, Nagichettiar Satyamurthy, Sung-Cheng Huang, Ernest M Wright, Jorge R Barrio. Am J Physiol Cell Physiol 2013
77
16

SGLT2 mediates glucose reabsorption in the early proximal tubule.
Volker Vallon, Kenneth A Platt, Robyn Cunard, Jana Schroth, Jean Whaley, Scott C Thomson, Hermann Koepsell, Timo Rieg. J Am Soc Nephrol 2011
337
16

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.
Bowen Lin, Nobutaka Koibuchi, Yu Hasegawa, Daisuke Sueta, Kensuke Toyama, Ken Uekawa, MingJie Ma, Takashi Nakagawa, Hiroaki Kusaka, Shokei Kim-Mitsuyama. Cardiovasc Diabetol 2014
232
16

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes.
Hassan Rahmoune, Paul W Thompson, Joanna M Ward, Chari D Smith, Guizhu Hong, John Brown. Diabetes 2005
550
16


Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review.
Anu K Ramachandran, Subham Das, Alex Joseph. Curr Neuropharmacol 2021
3
66

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao. Cell Res 2020
16

Sotagliflozin: First Global Approval.
Anthony Markham, Susan J Keam. Drugs 2019
23
16

Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
Wei Meng, Bruce A Ellsworth, Alexandra A Nirschl, Peggy J McCann, Manorama Patel, Ravindar N Girotra, Gang Wu, Philip M Sher, Eamonn P Morrison, Scott A Biller,[...]. J Med Chem 2008
397
16

Phlorizin: a review.
Joel R L Ehrenkranz, Norman G Lewis, C Ronald Kahn, Jesse Roth. Diabetes Metab Res Rev 2005
556
16

C-Glycopyranosyl Arenes and Hetarenes: Synthetic Methods and Bioactivity Focused on Antidiabetic Potential.
Éva Bokor, Sándor Kun, David Goyard, Marietta Tóth, Jean-Pierre Praly, Sébastien Vidal, László Somsák. Chem Rev 2017
82
16

Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs.
Angelica Artasensi, Alessandro Pedretti, Giulio Vistoli, Laura Fumagalli. Molecules 2020
73
16

Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
Sumihiro Nomura, Shigeki Sakamaki, Mitsuya Hongu, Eiji Kawanishi, Yuichi Koga, Toshiaki Sakamoto, Yasuo Yamamoto, Kiichiro Ueta, Hirotaka Kimata, Keiko Nakayama,[...]. J Med Chem 2010
217
16

(1S)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-D-glucitol (TS-071) is a potent, selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for type 2 diabetes treatment.
Hiroyuki Kakinuma, Takahiro Oi, Yuko Hashimoto-Tsuchiya, Masayuki Arai, Yasunori Kawakita, Yoshiki Fukasawa, Izumi Iida, Naoko Hagima, Hiroyuki Takeuchi, Yukihiro Chino,[...]. J Med Chem 2010
96
16

Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.
R Grempler, L Thomas, M Eckhardt, F Himmelsbach, A Sauer, D E Sharp, R A Bakker, M Mark, T Klein, P Eickelmann. Diabetes Obes Metab 2012
396
16

Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus.
Masakazu Imamura, Keita Nakanishi, Takayuki Suzuki, Kazuhiro Ikegai, Ryota Shiraki, Takashi Ogiyama, Takeshi Murakami, Eiji Kurosaki, Atsushi Noda, Yoshinori Kobayashi,[...]. Bioorg Med Chem 2012
77
16

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
16

Natural Products in Cancer Therapy: Past, Present and Future.
Min Huang, Jin-Jian Lu, Jian Ding. Nat Prod Bioprospect 2021
59
16

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
16

Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.
Gregory A Roth, George A Mensah, Catherine O Johnson, Giovanni Addolorato, Enrico Ammirati, Larry M Baddour, Noël C Barengo, Andrea Z Beaton, Emelia J Benjamin, Catherine P Benziger,[...]. J Am Coll Cardiol 2020
16


Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial.
William T Cefalu, Lawrence A Leiter, Kun-Ho Yoon, Pablo Arias, Leo Niskanen, John Xie, Dainius A Balis, William Canovatchel, Gary Meininger. Lancet 2013
533
16

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
16

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
16

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
16


Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Zhe Xu, Lei Shi, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, Shuhong Liu, Peng Zhao, Hongxia Liu, Li Zhu,[...]. Lancet Respir Med 2020
8


A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Kris M White, Matthew J O'Meara, Veronica V Rezelj, Jeffrey Z Guo, Danielle L Swaney,[...]. Nature 2020
8

Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
Marc Desforges, Alain Le Coupanec, Philippe Dubeau, Andréanne Bourgouin, Louise Lajoie, Mathieu Dubé, Pierre J Talbot. Viruses 2019
565
8

Characterization of accessory genes in coronavirus genomes.
Christian Jean Michel, Claudine Mayer, Olivier Poch, Julie Dawn Thompson. Virol J 2020
89
8

Clinical testing for COVID-19.
Stephanie Ward, Andrew Lindsley, Josh Courter, Amal Assa'ad. J Allergy Clin Immunol 2020
53
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.